Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral glibenclamide for hyperglycaemia in premature infants
2021-005766-18Phase 2Active
- Sponsor
- Assistance Publique – Hôpitaux de Paris (AP-HP), par délégation : Direction de la Recherche Clinique et de l’Innovation
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of glibenclamide in hyperglycemia, sponsored by Assistance Publique – Hôpitaux de Paris (AP-HP), par délégation : Direction de la Recherche Clinique et de l’Innovation. Started May 2024; status: active.
02
Drugs
glibenclamide
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on 2021-005766-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005766-18.